Clinical Trial Update: Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics and pharmacodynamics of PR-15, a platelet-adhesion inhibitor, in thrombosis and acute coronary syndrome-relate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Stroke
• Thrombosis

Drugs mentioned

• PR-15 (PR-15)

Snippet

Sponsor: AdvanceCor GmbH | Conditions: Thrombosis, Acute Coronary Syndrome | Phase 1 | Status: COMPLETED